Pfizer Write-offs decreased by 99.3% to $32.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 90.7%, from $344.00M to $32.00M. Over 4 years (FY 2021 to FY 2025), Write-offs shows an upward trend with a 109.0% CAGR.
pfe_write_offs| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.00M | $38.00M | $183.00M | $31.00M | $27.00M | $229.00M | $263.00M | $270.00M | $57.00M | $172.00M | $2.91B | $136.00M | $295.00M | $649.00M | $3.16B | $344.00M | $154.00M | $366.00M | $4.41B | $32.00M |
| QoQ Change | — | +22.6% | +381.6% | -83.1% | -12.9% | +748.1% | +14.8% | +2.7% | -78.9% | +201.8% | >999% | -95.3% | +116.9% | +120.0% | +387.2% | -89.1% | -55.2% | +137.7% | >999% | -99.3% |
| YoY Change | — | — | — | — | -12.9% | +502.6% | +43.7% | +771.0% | +111.1% | -24.9% | >999% | -49.6% | +417.5% | +277.3% | +8.7% | +152.9% | -47.8% | -43.6% | +39.3% | -90.7% |